Neuroradiological evaluation of demyelinating disease

Therapeutic Advances in Neurological Disorders

Volumn 6, Issue 4, 2013, Pages 249-268

  Tillema, Jan Mendelt ^a   Pirko, Istvan ^a  

^a MAYO CLINIC   (United States)

Author keywords

demyelinating disease; MRI; multiple sclerosis; neuroimaging

Indexed keywords

GADOLINIUM;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; BRAIN ATROPHY; BRAIN CORTEX LESION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; DECISION MAKING; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; DISEASE ACTIVITY; EXPANDED DISABILITY STATUS SCALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; MONITORING; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE LESION; POSTERIOR FOSSA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SPINAL CORD LESION; WHITE MATTER LESION;

EID: 84880379925     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285613478870     Document Type: Article

References (168)

1. Abou Zeid N. Pirko I. Erickson B. Weigand S. Thomsen K. Scheithauer B. et al. (2012) Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions. Neurology 78: 1655–1662.
2. Al-Okaili R. Krejza J. Woo J. Wolf R. O'Rourke D. Judy K. et al. (2007) Intraaxial brain masses: MR imaging-based diagnostic strategy - initial experience. Radiology 243: 539–550.
3. Anderson V. Fernando K. Davies G. Rashid W. Frost C. Fox N. et al. (2007) Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods. J Neuroimaging 17: 61–68.
4. Bagnato F. Jeffries N. Richert N. Stone R. Ohayon J. McFarland H. et al. (2003) Evolution of T 1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain 126:1782–1789.
5. Bakshi R. Benedict R. Bermel R. Caruthers S. Puli S. Tjoa C. et al. (2002) T 2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 59: 62–68.
6. Bakshi R. Dmochowski J. Shaikh Z. Jacobs L. (2001) Gray matter T 2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 185: 19–26.
7. Banwell B. Bar-Or A. Arnold D. Sadovnick D. Narayanan S. McGowan M. et al. (2011) Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 10: 436–445.
8. Banwell B. Tenembaum S. Lennon V. Ursell E. Kennedy J. Bar-Or A. et al. (2008) Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 70: 344–352.
9. Barkhof F. (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15: 239–245.
10. Barkhof F. Bruck W. de Groot C. Bergers E. Hulshof S. Geurts J. et al. (2003) Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 60: 1073–1081.
11. Barkhof F. Filippi M. Miller D. Scheltens P. Campi A. Polman C. et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120: 2059–2069.
12. Batista S. Zivadinov R. Hoogs M. Bergsland N. Heininen-Brown M. Dwyer M. et al. (2012) Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis.J Neurol 259: 139–146.
13. Benedict R. Ramasamy D. Munschauer F. Weinstock-Guttman B. Zivadinov R. (2009) Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy.J Neurol Neurosurg Psychiatry 80: 201–206.
14. Bermel R. Bakshi R. (2006) The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 5: 158–170.
15. Bermel R. Puli S. Rudick R. Weinstock-Guttman B. Fisher E. Munschauer F. III. et al. (2005) Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T 2 hypointensity. Arch Neurol 62: 1371–1376.
16. Bian W. Harter K. Hammond-Rosenbluth K. Lupo J. Xu D. Kelley D. et al. (2012) A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult Scler, in press.
17. Bitsch A. Kuhlmann T. Stadelmann C. Lassmann H. Lucchinetti C. Bruck W. (2001) A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 49: 793–796.
18. Bot J. Barkhof F. Lycklama a Nijeholt G. Bergers E. Polman C. Ader H. et al. (2000) Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosis. Eur Radiol 10: 753–758.
19. Bot J. Barkhof F. Lycklama a. Nijeholt G. van Schaardenburg D. Voskuyl A. Ader H. et al. (2002) Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 223: 46–56.
20. Brex P. Ciccarelli O. O'Riordan J. Sailer M. Thompson A. Miller D. (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346: 158–164.
21. Brex P. Molyneux P. Smiddy P. Barkhof F. Filippi M. Yousry T. et al. (2001) The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS. Neurology 57: 2185–2190.
22. Brex P. Parker G. Leary S. Molyneux P. Barker G. Davie C. et al. (2000) Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T 1 weighted images, T 1 relaxation times, and metabolite concentrations.J Neurol Neurosurg Psychiatry 68: 627–632.
23. Brodsky M. Nazarian S. Orengo-Nania S. Hutton G. Buckley E. Massey E. et al. for the Optic Neuritis Study Group (2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65: 727–732.
24. Butteriss D. Ismail A. Ellison D. Birchall D. (2003) Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol 76: 662–665.
25. Callen D. Shroff M. Branson H. Li D. Lotze T. Stephens D. et al. (2009 a) Role of MRI in the differentiation of ADEM from MS in children. Neurology 72: 968–973.
26. Callen D. Shroff M. Branson H. Lotze T. Li D. Stephens D. et al. (2009 b) MRI in the diagnosis of pediatric multiple sclerosis. Neurology 72: 961–967.
27. Campi A. Pontesilli S. Gerevini S. Scotti G. (2000) Comparison of MRI pulse sequences for investigation of lesions of the cervical spinal cord. Neuroradiology 42: 669–675.
28. Caramanos Z. Francis S. Narayanan S. Lapierre Y. Arnold D. (2012) Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis. Arch Neurol 69: 89–95.
29. Chard D. Brex P. Ciccarelli O. Griffin C. Parker G. Dalton C. et al. (2003) The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study. J Neurol Neurosurg Psychiatry 74: 1551–1554.
30. Charil A. Yousry T. Rovaris M. Barkhof F. de Stefano N. Fazekas F. et al. (2006) MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol 5: 841–852.
31. Chen J. Collins D. Freedman M. Atkins H. Arnold D. (2005) Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients. Neuroimage 25: 1272–1278.
32. Ciccarelli O. Giugni E. Paolillo A. Mainero C. Gasperini C. Bastianello S. et al. (1999) Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis. Eur J Neurol 6: 455–459.
33. Ciccarelli O. Parker G. Toosy A. Wheeler-Kingshott C. Barker G. Boulby P. et al. (2003) From diffusion tractography to quantitative white matter tract measures: a reproducibility study. Neuroimage 18: 348–359.
34. Ciccarelli O. Toosy A. Hickman S. Parker G. Wheeler-Kingshott C. Miller D. et al. (2005) Optic radiation changes after optic neuritis detected by tractography-based group mapping. Hum Brain Mapp 25: 308–316.
35. Ciccarelli O. Werring D. Wheeler-Kingshott C. Barker G. Parker G. Thompson A. et al. (2001) Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 56: 926–933.
36. Colletti P. (2008) Nephrogenic systemic fibrosis and gadolinium: a perfect storm. AJR Am J Roentgenol 191: 1150–1153.
37. Cotton F. Weiner H. Jolesz F. Guttmann C. (2003) MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 60: 640–646.
38. Dale R. de Sousa C. Chong W. Cox T. Harding B. Neville B. (2000) Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 123: 2407–2422.
39. Daumer M. Neuhaus A. Morrissey S. Hintzen R. Ebers G. (2009) MRI as an outcome in multiple sclerosis clinical trials. Neurology 72: 705–711.
40. de Graaf W. Zwanenburg J. Visser F. Wattjes M. Pouwels P. Geurts J. et al. (2012) Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR. Eur Radiol 22: 221–231.
41. de Seze J. Debouverie M. Zephir H. Lebrun C. Blanc F. Bourg V. et al. (2007) Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol 64: 1426–1432.
42. de Stefano N. Battaglini M. Smith S. (2007) Measuring brain atrophy in multiple sclerosis. J Neuroimaging 17(Suppl. 1): 10S–15S.
43. Dousset V. Brochet B. Deloire M. Lagoarde L. Barroso B. Caille J. et al. (2006) MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR Am J Neuroradiol 27: 1000–1005.
44. Dousset V. Gayou A. Brochet B. Caille J. (1998) Early structural changes in acute MS lesions assessed by serial magnetization transfer studies. Neurology 51: 1150–1155.
45. Dousset V. Grossman R. Ramer K. Schnall M. Young L. Gonzalez-Scarano F. et al. (1992) Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 182: 483–491.
46. Filippi M. Iannucci G. Tortorella C. Minicucci L. Horsfield M. Colombo B. et al. (1999 a) Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 52: 588–594.
47. Filippi M. Rocca M. (2004) Magnetization transfer magnetic resonance imaging in the assessment of neurological diseases. J Neuroimaging 14: 303–313.
48. Filippi M. Rocca M. Moiola L. Martinelli V. Ghezzi A. Capra R. et al. (1999 b) MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology 53: 1705–1710.
49. Filippi M. Yousry T. Baratti C. Horsfield M. Mammi S. Becker C. et al. (1996) Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain 119: 1349–1355.
50. Fisniku L. Brex P. Altmann D. Miszkiel K. Benton C. Lanyon R. et al. (2008) Disability and T 2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 131: 808–817.
51. Fox N. Jenkins R. Leary S. Stevenson V. Losseff N. Crum W. et al. (2000) Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology 54: 807–812.
52. Gawne-Cain M. O'Riordan J. Thompson A. Moseley I. Miller D. (1997) Multiple sclerosis lesion detection in the brain: a comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo. Neurology 49: 364–370.
53. Gean-Marton A. Vezina L. Marton K. Stimac G. Peyster R. Taveras J. et al. (1991) Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology 180: 215–221.
54. Geurts J. Pouwels P. Uitdehaag B. Polman C. Barkhof F. Castelijns J. (2005) Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 236: 254–260.
55. Geurts J. Roosendaal S. Calabrese M. Ciccarelli O. Agosta F. Chard D. et al. (2011) Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 76: 418–424.
56. Griffin C. Chard D. Ciccarelli O. Kapoor B. Barker G. Thompson A. et al. (2001) Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. Mult Scler 7: 290–297.
57. Grimaud J. Millar J. Thorpe J. Moseley I. McDonald W. Miller D. (1995) Signal intensity on MRI of basal ganglia in multiple sclerosis. J Neurol Neurosurg Psychiatry 59: 306–308.
58. Grossman R. Braffman B. Brorson J. Goldberg H. Silberberg D. Gonzalez-Scarano F. (1988) Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 169: 117–122.
59. Grossman R. Gonzalez-Scarano F. Atlas S. Galetta S. Silberberg D. (1986) Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 161: 721–725.
60. Haacke E. Ayaz M. Khan A. Manova E. Krishnamurthy B. Gollapalli L. et al. (2007) Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 26: 256–264.
61. Haemel A. Sadowski E. Shafer M. Djamali A. (2011) Update on nephrogenic systemic fibrosis: are we making progress? Int J Dermatol 50: 659–666.
62. Hagemeier J. Weinstock-Guttman B. Bergsland N. Brown M. Carl E. Kennedy C. et al. (2012) Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR Am J Neuroradiol, in press.
63. Hiehle J. Jr Grossman R. Ramer K. Gonzalez-Scarano F. Cohen J. (1995) Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 16: 69–77.
64. Ingle G. Sastre-Garriga J. Miller D. Thompson A. (2005) Is inflammation important in early PPMS? a longitudinal MRI study. J Neurol Neurosurg Psychiatry 76: 1255–1258.
65. Inglese M. Grossman R. Filippi M. (2005) Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution. J Neuroimaging 15(4 Suppl.): 22S–29S.
66. Janardhan V. Suri S. Bakshi R. (2007) Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T 1 shortening. Radiology 244: 823–831.
67. Jasperse B. Valsasina P. Neacsu V. Knol D. de Stefano N. Enzinger C. et al. (2007) Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX. J Magn Reson Imaging 26: 881–885.
68. Kappos L. Moeri D. Radue E. Schoetzau A. Schweikert K. Barkhof F. et al. (1999) Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 353: 964–969.
69. Ketelslegers I. Neuteboom R. Boon M. Catsman-Berrevoets C. Hintzen R. (2010) A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology 74: 1412–1415.
70. Kidd D. Thorpe J. Kendall B. Barker G. Miller D. McDonald W. et al. (1996) MRI dynamics of brain and spinal cord in progressive multiple sclerosis.J Neurol Neurosurg Psychiatry 60: 15–19.
71. Kim S. Kim W. Li X. Jung I. Kim H. (2012) Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder? Mult Scler, in press.
72. Krupp L. Banwell B. Tenembaum S. (2007) Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 68(16 Suppl. 2): S7–S12.
73. Kutzelnigg A. Lassmann H. (2005) Cortical lesions and brain atrophy in MS. J Neurol Sci 233: 55–59.
74. Laule C. Vavasour I. Whittall K. Oger J. Paty D. Li D. et al. (2003) Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis. J Neurol 250: 924–931.
75. Leake J. Albani S. Kao A. Senac M. Billman G. Nespeca M. et al. (2004) Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infectious Disease J 23: 756–764.
76. Lebel R. Eissa A. Seres P. Blevins G. Wilman A. (2012) Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis. Mult Scler 18: 433–441.
77. Lebrun C. Bensa C. Debouverie M. Wiertlevski S. Brassat D. de Seze J. et al. (2009) Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol 66: 841–846.
78. Lebrun C. Blanc F. Brassat D. Zephir H. de Seze J. CFSEP (2010) Cognitive function in radiologically isolated syndrome. Mult Scler 16: 919–925.
79. Leist T. Gobbini M. Frank J. McFarland H. (2001) Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis. Arch Neurol 58: 57–60.
80. Lennon V. Kryzer T. Pittock S. Verkman A. Hinson S. (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473–477.
81. Lennon V. Wingerchuk D. Kryzer T. Pittock S. Lucchinetti C. Fujihara K. et al. (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106–2112.
82. Levesque I. Sled J. Narayanan S. Santos A. Brass S. Francis S. et al. (2005) The role of edema and demyelination in chronic T 1 black holes: a quantitative magnetization transfer study. J Magn Reson Imaging 21: 103–110.
83. Losseff N. Miller D. Kidd D. Thompson A. (2001 a) The predictive value of gadolinium enhancement for long term disability in relapsing–remitting multiple sclerosis - preliminary results. Mult Scler 7: 23–25.
84. Losseff N. Wang L. Lai H. Yoo D. Gawne-Cain M. McDonald W. et al. (1996) Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 119: 2009–2019.
85. Losseff N. Wang L. Miller D. Thompson A. (2001 b) T 1 hypointensity of the spinal cord in multiple sclerosis. J Neurol 248: 517–521.
86. Lucchinetti C. Gavrilova R. Metz I. Parisi J. Scheithauer B. Weigand S. et al. (2008) Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 131: 1759–1775.
87. Lucchinetti C. Popescu B. Bunyan R. Moll N. Roemer S. Lassmann H. et al. (2011) Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365: 2188–2197.
88. Masdeu J. Moreira J. Trasi S. Visintainer P. Cavaliere R. Grundman M. (1996) The open ring. A new imaging sign in demyelinating disease.J Neuroimaging 6: 104–107.
89. Masdeu J. Quinto C. Olivera C. Tenner M. Leslie D. Visintainer P. (2000) Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 54: 1427–1433.
90. McDonald W. Compston A. Edan G. Goodkin D. Hartung H. Lublin F. et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121–127.
91. McKeon A. Fryer J. Apiwattanakul M. Lennon V. Hinson S. Kryzer T. et al. (2009) Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol 66: 1134–1138.
92. Mikaeloff Y. Adamsbaum C. Husson B. Vallee L. Ponsot G. Confavreux C. et al. (2004) MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 127: 1942–1947.
93. Mikaeloff Y. Caridade G. Husson B. Suissa S. Tardieu M. (2007) Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatric Neurol 11 (2): 90–95.
94. Miller D. Barkhof F. Frank J. Parker G. Thompson A. (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125: 1676–1695.
95. Miller D. Rudge P. Johnson G. Kendall B. Macmanus D. Moseley I. et al. (1988) Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 111: 927–939.
96. Minneboo A. Uitdehaag B. Ader H. Barkhof F. Polman C. Castelijns J. (2005) Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients. Neurology 65: 56–61.
97. Mistry N. Tallantyre E. Dixon J. Galazis N. Jaspan T. Morgan P. et al. (2011) Focal multiple sclerosis lesions abound in ‘normal appearing white matter’. Mult Scler 17: 1313–1323.
98. Molyneux P. Filippi M. Barkhof F. Gasperini C. Yousry T. Truyen L. et al. (1998) Correlations between monthly enhanced MRI lesion rate and changes in T 2 lesion volume in multiple sclerosis. Ann Neurol 43: 332–339.
99. Montalban X. Tintore M. Swanton J. Barkhof F. Fazekas F. Filippi M. et al. (2010) MRI criteria for MS in patients with clinically isolated syndromes. Neurology 74: 427–434.
100. Morgen K. Jeffries N. Stone R. Martin R. Richert N. Frank J. et al. (2001) Ring-enchancement in multiple sclerosis: marker of disease severity. Mult Scler 7: 167–171.
101. Morrissey S. Miller D. Kendall B. Kingsley D. Kelly M. Francis D. et al. (1993) The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 116: 135–146.
102. Moseley I. Miller D. Gass A. (1998) The contribution of magnetic resonance imaging to the assessment of optic nerve and spinal cord involvement in multiple sclerosis. J Neurol Neurosurg Psychiatry 64(Suppl. 1): S15–S20.
103. Naismith R. Xu J. Tutlam N. Snyder A. Benzinger T. Shimony J. et al. (2009) Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology 72: 589–594.
104. Naismith R. Xu J. Tutlam N. Trinkaus K. Cross A. Song S. (2010) Radial diffusivity in remote optic neuritis discriminates visual outcomes. Neurology 74: 1702–1710.
105. Nielsen A. Kinkel R. Tinelli E. Benner T. Cohen-Adad J. Mainero C. (2012) Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2. J Magnet Resonance Imaging 35: 537–542.
106. Noseworthy J. Lucchinetti C. Rodriguez M. Weinshenker B. (2000) Multiple sclerosis. N Engl J Med 343: 938–952.
107. O'Riordan J. Thompson A. Kingsley D. MacManus D. Kendall B. Rudge P. et al. (1998) The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 121: 495–503.
108. Offenbacher H. Fazekas F. Schmidt R. Freidl W. Flooh E. Payer F. et al. (1993) Assessment of MRI criteria for a diagnosis of MS. Neurology 43: 905–909.
109. Okuda D. Mowry E. Beheshtian A. Waubant E. Baranzini S. Goodin D. et al. (2009) Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 72: 800–805.
110. Okuda D. Mowry E. Cree B. Crabtree E. Goodin D. Waubant E. et al. (2011) Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 76: 686–692.
111. Oreja-Guevara C. Charil A. Caputo D. Cavarretta R. Sormani M. Filippi M. (2006) Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis. Arch Neurol 63: 736–740.
112. Paty D. Li D. (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS / MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 43: 662–667.
113. Pichiecchio A. Tavazzi E. Poloni G. Ponzio M. Palesi F. Pasin M. et al. (2012) Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach. Mult Scler 18: 817–824.
114. Pirko I. Fricke S. Johnson A. Rodriguez M. Macura S. (2005) Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals. NeuroRx 2: 250–264.
115. Pirko I. Johnson A. Ciric B. Gamez J. Macura S. Pease L. et al. (2004) In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies. Faseb J 18: 179–182.
116. Pirko I. Lucchinetti C. Sriram S. Bakshi R. (2007) Gray matter involvement in multiple sclerosis. Neurology 68: 634–642.
117. Pittock S. Lennon V. Krecke K. Wingerchuk D. Lucchinetti C. Weinshenker B. (2006 a) Brain abnormalities in neuromyelitis optica. Arch Neurol 63: 390–396.
118. Pittock S. Weinshenker B. Lucchinetti C. Wingerchuk D. Corboy J. Lennon V. (2006 b) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63: 964–968.
119. Polman C. Reingold S. Banwell B. Clanet M. Cohen J. Filippi M. et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292–302.
120. Polman C. Reingold S. Edan G. Filippi M. Hartung H. Kappos L. et al. (2005 a) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58: 840–846.
121. Popescu B. Lucchinetti C. (2012) Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol 12: 11.
122. Rocca M. Agosta F. Sormani M. Fernando K. Tintore M. Korteweg T. et al. (2008) A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol, in press.
123. Rovaris M. Agosta F. Sormani M. Inglese M. Martinelli V. Comi G. et al. (2003) Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 126: 2323–2332.
124. Rovira A. Swanton J. Tintore M. Huerga E. Barkhof F. Filippi M. et al. (2009) A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol 66: 587–592.
125. Sadowski E. Bennett L. Chan M. Wentland A. Garrett A. Garrett R. et al. (2007) Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 243: 148–157.
126. Sailer M. O'Riordan J. Thompson A. Kingsley D. MacManus D. McDonald W. et al. (1999) Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology 52: 599–606.
127. Saindane A. Cha S. Law M. Xue X. Knopp E. Zagzag D. (2002) Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 23: 1378–1386.
128. Santos A. Narayanan S. de Stefano N. Tartaglia M. Francis S. Arnaoutelis R. et al. (2002) Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J Neurol 249: 662–668.
129. Sastre-Garriga J. Ingle G. Chard D. Cercignani M. Ramio-Torrenta L. Miller D. et al. (2005) Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain 128: 1454–1460.
130. Sastre-Garriga J. Ingle G. Chard D. Ramio-Torrenta L. Miller D. Thompson A. (2004) Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Neuroimage 22: 353–359.
131. Seewann A. Kooi E. Roosendaal S. Pouwels P. Wattjes M. van der Valk P. et al. (2012) Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 78: 302–308.
132. Shimizu J. Hatanaka Y. Hasegawa M. Iwata A. Sugimoto I. Date H. et al. (2010) IFNbeta-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 75:1423–1427.
133. Silver N. Lai M. Symms M. Barker G. McDonald I. Miller D. (1999) Serial gadolinium-enhanced and magnetization transfer imaging to investigate the relationship between the duration of blood-brain barrier disruption and extent of demyelination in new multiple sclerosis lesions.J Neurol 246: 728–730.
134. Simon J. (2006) Brain atrophy in multiple sclerosis: what we know and would like to know. Mult Scler 12: 679–687.
135. Siva A. Saip S. Altintas A. Jacob A. Keegan B. Kantarci O. (2009) Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler 15: 918–927.
136. Stevenson V. Gawne-Cain M. Barker G. Thompson A. Miller D. (1997) Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast FLAIR and fast spin echo. J Neurol 244: 119–124.
137. Tenembaum S. Chamoles N. Fejerman N. (2002) Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 59: 1224–1231.
138. Tenembaum S. Chitnis T. Ness J. Hahn J. (2007) Acute disseminated encephalomyelitis. Neurology 68(16 Suppl. 2): S23–S36.
139. Thompson A. Kermode A. Wicks D. MacManus D. Kendall B. Kingsley D. et al. (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 29: 53–62.
140. Thompson A. Miller D. Youl B. MacManus D. Moore S. Kingsley D. et al. (1992) Serial gadolinium-enhanced MRI in relapsing / remitting multiple sclerosis of varying disease duration. Neurology 42: 60–63.
141. Thorpe J. Kidd D. Moseley I. Kenndall B. Thompson A. MacManus D. et al. (1996) Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46: 373–378.
142. Tiberio M. Chard D. Altmann D. Davies G. Griffin C. Rashid W. et al. (2005) Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology 64: 1001–1007.
143. Tillema J. Leach J. Pirko I. (2012) Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders. Mult Scler, in press.
144. Tjoa C. Benedict R. Weinstock-Guttman B. Fabiano A. Bakshi R. (2005) MRI T 2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 234: 17–24.
145. Torisu H. Kira R. Ishizaki Y. Sanefuji M. Yamaguchi Y. Yasumoto S. et al. (2010) Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Developm 32: 454–462.
146. Traboulsee A. Dehmeshki J. Brex P. Dalton C. Chard D. Barker G. et al. (2002) Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS. Neurology 59: 126–128.
147. Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59: 499–505.
148. Truyen L. van Waesberghe J. van Walderveen M. van Oosten B. Polman C. Hommes O. et al. (1996) Accumulation of hypointense lesions (“black holes”) on T 1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47: 1469–1476.
149. Tubridy N. Coles A. Molyneux P. Compston D. Barkhof F. Thompson A. et al. (1998) Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features. Brain 121: 225–231.
150. Uhlenbrock D. Sehlen S. (1989) The value of T1-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE). Neuroradiology 31: 203–212.
151. van Waesberghe J. Kamphorst W. de Groot C. van Walderveen M. Castelijns J. Ravid R. et al. (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46: 747–754.
152. van Walderveen M. Barkhof F. Hommes O. Polman C. Tobi H. Frequin S. et al. (1995) Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 45: 1684–1690.
153. van Walderveen M. Kamphorst W. Scheltens P. van Waesberghe J. Ravid R. Valk J. et al. (1998) Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 50: 1282–1288.
154. van Walderveen M. Lycklama A. Ader H. Jongen P. Polman C. Castelijns J. et al. (2001) Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol 58: 76–81.
155. Vellinga M. Oude Engberink R. Seewann A. Pouwels P. Wattjes M. van der Pol S. et al. (2008) Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 131: 800–807.
156. Vishwas M. Chitnis T. Pienaar R. Healy B. Grant P. (2009) Tract-based analysis of callosal, projection, and association pathways in pediatric patients with multiple sclerosis: a preliminary study. AJNR Am J Neuroradiol, in press.
157. Waters P. McKeon A. Leite M. Rajasekharan S. Lennon V. Villalobos A. et al. (2012) Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays. Neurology 78: 665–671.
158. Werring D. Clark C. Barker G. Thompson A. Miller D. (1999) Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 52: 1626–1632.
159. Wingerchuk D. Hogancamp W. O'Brien P. Weinshenker B. (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107–1114.
160. Wingerchuk D. Lennon V. Pittock S. Lucchinetti C. Weinshenker B. (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485–1489.
161. Wingerchuk D. Lucchinetti C. (2007) Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol 20: 343–350.
162. Yiu E. Kornberg A. Ryan M. Coleman L. Mackay M. (2009) Acute transverse myelitis and acute disseminated encephalomyelitis in childhood: spectrum or separate entities? J Child Neurol 24: 287–296.
163. Young N. Weinshenker B. Parisi J. Scheithauer B. Giannini C. Roemer S. et al. (2010) Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain 133: 333–348.
164. Yu C. Zhu C. Li K. Xuan Y. Qin W. Sun H. et al. (2007) Relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis: differentiation at diffusion-tensor MR imaging of corpus callosum. Radiology 244: 249–256.
165. Zhou F. Shiroishi M. Gong H. Zee C. (2010) Multiple sclerosis: hyperintense lesions in the brain on T1-weighted MR images assessed by diffusion tensor imaging. J Magnet Resonance Imaging 31: 789–795.
166. Zivadinov R. Bakshi R. (2004) Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. Front Biosci 9: 647–664.
167. Zivadinov R. Cox J. (2007) Neuroimaging in multiple sclerosis. Int Rev Neurobiol 79: 449–474.
168. Zivadinov R. Leist T. (2005) Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging 15(4 Suppl.): 10S–21S.